Results 131 to 140 of about 7,431 (174)

Reduction of Simian-Human Immunodeficiency Virus 89.6P Viremia in Rhesus Monkeys by Recombinant Modified Vaccinia Virus Ankara Vaccination

open access: green, 2001
Dan H. Barouch   +15 more
openalex   +1 more source

Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study. [PDF]

open access: yesClin Infect Dis
Fontán-Vela M   +36 more
europepmc   +1 more source

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. [PDF]

open access: yesCommun Med (Lond)
Chiuppesi F   +12 more
europepmc   +1 more source

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP [PDF]

open access: bronze, 2016
Tommy Rampling   +30 more
openalex   +1 more source

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans. [PDF]

open access: yesNPJ Vaccines, 2020
Capone S   +12 more
europepmc   +1 more source

Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine

open access: yesEmerging Infectious Diseases, 2015
Rory D. de Vries   +8 more
doaj   +1 more source

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.

open access: yesJAMA
Collier AY   +6 more
europepmc   +1 more source

Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. [PDF]

open access: yesLancet Reg Health Eur
Ghosn J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy